Literature DB >> 23093238

GIST: advances in tyrosine kinase inhibitors enhance laparoscopic resection even in advanced disease.

Christof Hottenrott.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23093238     DOI: 10.1007/s00464-012-2599-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  25 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

2.  Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer.

Authors:  Dimitrios H Roukos
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

3.  Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends.

Authors:  Christos G Katsios; George Baltogiannis; Dimitrios H Roukos
Journal:  Expert Rev Anticancer Ther       Date:  2010-04       Impact factor: 4.512

Review 4.  Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Authors:  D H Roukos
Journal:  Pharmacogenomics J       Date:  2010-10-26       Impact factor: 3.550

5.  Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes.

Authors:  Theodore Liakakos; Dimitrios H Roukos
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

6.  'Big' science: genome regulatory networks and novel molecular tools to improve health.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

7.  Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Med Devices       Date:  2011-03       Impact factor: 3.166

8.  Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2011-05       Impact factor: 2.533

9.  Cancer genome explosion and systems biology: impact on surgical oncology?

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2011-01       Impact factor: 5.344

Review 10.  Nilotinib: a novel, selective tyrosine kinase inhibitor.

Authors:  Jean-Yves Blay; Margaret von Mehren
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.